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Abstract
Im m unophenotyping o f  b lood lym phocyte  
subpopulations in neonates and young 
infants is ham pered  by the lim ited  am ount 
o f b lood that can be collected. C ontam ina­
tion o f  the flow cytom etric “lym ph o-gate” 
by norm oblasts and analysed erythro­
cytes, and therefore the underestim ation  
o f the relative frequencies o f  lym phocyte  
subpopulations, interferes with the p re­
cise calculation o f  absolute counts.
A  m icroassay was developed by adapt­
ing the lysed  w hole b lood technique. Triple 
im m unostaining in a single antibody  
staining step was used  to reduce w ashing  
steps and cell loss. Introduction o f  a triple 
staining for CD71 (expressed by erythroid  
precursors), glycophorin A  (GpA, ex­
pressed  by all erythroid cells), and CD45 
(expressed by all leucocytes) perm itted  
the relative frequencies o f  norm oblasts  
(CD717GpA7CD45" population) and un- 
lysed  erythrocytes (CD71'/GpA7CD45‘ 
population)to be identified  and m easured  
within the “lym ph o-gate” o f  neonatal cord  
blood sam ples. Particularly high frequen­
cies were found (m edian: 31%) in cord  
blood sam ples from  preterm  neonates. 
These erythroid cells disappear rapidly by 
1 week o f  age The relative frequencies o f 
erythroid cells can be used  to calculate  
correct lym phocyte subpopulation values. 
U sing only 0.5-0.8 m l o f  blood, th is m icro ­
assay would also be suitable for rapid p re­
natal im m unodiagnosis o f  congenital im ­
m unodeficiencies.
(Arch Dis Child Fetal Neonatal Ed 1999;80:F226-F229)
Keywords: erythroid cell contamination; lymphocyte 
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Immunophenotyping of blood lymphocyte 
subpopulations is an important tool in the 
diagnosis and follow up of children with 
congenital immunodeficiencies, H IV infection, 
or other immune disorders. It is also needed for 
investigation of age related maturational proc­
esses within the immune system in childhood. 
Immunophenotyping of blood lymphocytes 
used to be performed after density gradient 
separation, but the lysed whole blood tech­
nique is preferred now because it prevents 
selective cell loss, requires smaller amounts of 
blood, and results in more accurate determina­
tion of absolute lymphocyte counts.1-3
In neonates and young infants, several prob­
lems are encountered in flow cytometric
immunophenotyping of blood lymphocytes. 
The limited blood volume in these children 
and technical difficulties in venepuncture 
restrict the amount of blood that can be 
collected. In neonates the flow cytometric 
“lympho-gate” can be contaminated with nor­
moblasts and unlysed erythrocytes (fig 1).4 
Normoblasts are comparable in size and 
surface membrane to lymphocytes and thus 
have similar flow cytometric forward scatter 
(FSC) and side scatter (SSC) characteristics. 
Neonatal erythrocytes are relatively resistant to 
osmotic lysis.4 Some of them are sufficiently 
large to collect in the flow cytometric lympho- 
gate. This erythroid cell contamination ham­
pers the determination of the relative frequen­
cies of lymphocyte subpopulations and thus 
calculation of absolute counts from the total 
white cell count, which is generally determined 
as the total nucleated cell count.3 In neonates 
the presence of normoblasts can also interfere 
with the determination of the total white cell 
count, because normoblasts are nucleated, and 
are therefore included in the total count.
To overcome these difficulties, we developed 
a lysed whole blood microassay with triple 
immunostaining for the identification of eryth­
roid cells and correction for erythroid cell con­
tamination within the lympho-gate.
M ethods
Twenty one neonatal cord blood samples were 
collected by venepuncture immediately after 
clamping of the cord. The blood was kept at 
room temperature until labelling with mono­
clonal antibodies was performed within 12 
hours of sampling. Peripheral blood was drawn 
by venepuncture from nine healthy adult 
volunteers between 20 and 40 years of age, and 
at 1 week of age from 14 neonates whose cord 
blood had been studied before. EDTA was 
used as an anticoagulant.
Informed consent was obtained according to 
the guidelines of the Medical Ethics Com­
mittee of the Erasmus University Rotterdam/ 
University Hospital Rotterdam in all cases.
The following monoclonal antibodies were 
used: CD3 (Leu-4a), CD4 (Leu-3a), CD8 
(Leu-2a), CD16 (Leu-11c), CD19 (Leu-12), 
CD56 (Leu-19), CD71 (anti-transferrin recep­
tor), CD45 (HLE1), IgG1 and IgG2 (isotype 
controls) (Becton Dickinson, San Jose, CA), 
CD14 (My4), CD19 (B4) (Coulter, Hialeah, 
FL), CD3 (Hit3a), glycophorinA (GpA) (GA- 
R2), (Pharmingen, San Diego, CA), CD15 
(CLBgran2) (Central Laboratory of the Blood
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Transfusion Service, Amsterdam, The Nether­
lands). All monoclonal antibodies were conju­
gated with fluorescein isothiocyanate (FITC), 
phycoerythrin (PE), or the duochrome PE- 
Cyanin5 (PE-Cy5).
Blood samples (100, 40, 20, or 10 ^l ) were 
incubated with titrated monoclonal antibodies 
for 10 minutes at room temperature. After two 
washes with phosphate buffered saline contain­
ing 0.1% NaN3 and 0.5% bovine serum 
albumin, erythrocytes were lysed with Lysing 
Solution (Becton Dickinson) according to the 
manufacturer’s instructions. Before lysis the 
cell pellet was loosened to prevent incomplete 
lysis of erythrocytes.
The samples were analysed using a FACS- 
can flow cytometer (Becton Dickinson). In­
strument settings were determined with cells 
labelled with FITC, PE, and PE-Cy5 conju­
gated monoclonal antibodies and unstained 
cells. After gating of lymphocytes on the basis 
of FSC and SSC (checked by CD14, CD15, 
and CD45 monoclonal antibody staining), 
8000 events were acquired. The data were ana­
lysed using FACScan software (Becton Dickin­
son) in dot blots, with optimal quadrant setting 
checked by histogram analysis, if necessary.
The total nucleated cell count was deter­
mined on an H1 Technicon haemocytometer 
(Bayer, Tarrytown, NY). The relative frequency 
of normoblasts was carefully determined by 
manual differentiation of at least 400 nucleated 
cells. The total leucocyte count was determined 
according to the following formula:
to ta l nucleated  cell co u n t X (100—% o f  norm oblasts) X 10"2
The relative frequencies of lymphocyte sub­
populations were calculated according to the 
following formula:
p ercen tage  o f  pop u la tio n  w ith in  th e  lym pho-gate X 10a
1 0 0 —(percen tage o f  no rm ob las ts  p lu s  p ercen tage  o f  unlysed  
ery th rocy tes w ith in  th e  lym pho  gate)
The Wilcoxon rank sum test or Friedman’s 
test were used to compare two or more differ­
ent techniques used in one blood sample, 
respectively (a = 0.05).
Results
D EV ELO PM EN T O F MICROASSAY
We incubated 100, 40, 20, and 10 ^l of blood 
with monoclonal antibodies. When using 20 ^l 
of blood, at least 100 000 nucleated cells 
remained available after completion of the 
staining procedure in all samples tested, as 
determined by use of a cell counter (Coulter 
Counter; Hialeah, FL). However, when using 
10 ^l of blood, major and variable cell loss was 
observed. Relative frequencies of lymphocyte 
subpopulations determined in parallel with 
either 100 ^l or 20 ^l of blood per test tube gave 
fully comparable results in five separate neona­
tal blood samples. Therefore, 20 ^l of blood 
incubated with 20 ^l of each monoclonal anti­
body per test tube was used in all further 
experiments.
The determination of the relative frequen­
cies of lymphocyte subpopulations by either 
double or triple immunostaining was com­
pared in one adult and six cord blood 
samples—for example, triple CD4/CD8/CD3 
vs double CD4/CD8, CD4/CD3 and CD8/ 
CD3 immunostaining. When using triple 
immunostaining, monoclonal antibodies were 
either incubated consecutively, with each incu­
bation followed by two washes, or all together. 
No significant differences were found between 
the relative frequencies of lymphocyte sub­
populations, as determined by the different 
staining methods. Therefore, in all further 
experiments only triple immunostaining was 
used with incubation of all three fluorochrome 
conjugated monoclonal antibodies simultane­
ously to speed up the microassay and minimise 
cell loss due to multiple washes.
D E T E C T IO N  O F ERY TH RO ID  CELL 
CO N TA M IN A TIO N
When a scatter gate is set around the 
lymphocyte population, it is generally not pos­
sible to exclude fully other contaminating cells 
without excluding lymphocytes. However, as 
long as the sum of the relative frequencies of B 
lymphocytes, T lymphocytes, and natural killer 
cells (the so-called “lympho-sum”) is at least 
95% (or 0.95), the lympho-gate is often 
considered to be placed correctly. The remain­
ing events within the lympho-gate are mono­
cytes, granulocytes, and unidentified events, 
which generally consist of dead cells and 
debris. In our neonatal cord blood samples the 
lympho-sum rarely reached 95% of the 
lympho-gate (table 1). In preterm neonates, in 
particular, the lympho-sum seemed to be far 
too low. This was caused by a relatively high 
frequency of unidentified events (fig 1).
Normoblasts express CD71 and GpA, 
whereas erythrocytes express only GpA. In 
contrast, leucocytes express CD45, unlike nor­
moblasts and erythrocytes. Therefore, CD71+/ 
GpA+/CD45- cells within the lympho-gate can 
be regarded as normoblasts, whereas unlysed 
erythrocytes have the CD71VGpA7CD45- 
immunophenotype.5 By triple immunostaining 
with CD71-FITC, GpA-PE, and CD45-PE- 
Cy5, these unidentified events could be identi­
fied as contamination by normoblasts and in 
some samples by unlysed erythrocytes as well 
(fig 2) (table 1). The FSC and SSC of these 
normoblasts and unlysed erythrocytes was 
checked (“back-gating”), and was found to be 
relatively low, as expected for these cells (figs 
2C and D).
A small percentage of events remained 
unidentified—that is, they were neither CD45+ 
leucocytes, nor CD71+/GpA+/CD45- normo­
blasts, nor CD71VGpA7CD45- unlysed eryth­
rocytes (left lower quadrant of dot plot in fig 
2B). These events may represent dead cells and 
debris.
ERY TH RO ID  CELL C O N TA M IN A TIO N  IN  N EO NA TA L 
BLOOD
CD71/GpA/CD45 staining was used to deter­
mine the relative counts of normoblasts and 
unlysed erythrocytes and to calculate the 
relative counts of lymphocyte subpopulations. 
The differences in relative frequencies of 
lymphocyte subpopulations in neonatal cord
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CD3/CD19/CD15-FITC
Figure 1 Flow cytometric immunophenotyping of neonatal cord blood lymphocytes reveals 
a high frequency of unidentified events within the lympho-gate. (A) Lympho-gate setting in 
neonatal cord blood, based upon FSC/SSC characteristics. (B) Composition of the 
lympho-gate in neonatal cord blood: many unidentified events and relatively high numbers 
of natural killer cells were observed. (C) Lympho-gate setting in adult blood. (D) 
Composition of the lympho-gate in adult blood: virtually no unidentified events and 
relatively low numbers of natural killer cells were observed. Quadrant 1: CD14+ 
contaminating monocytes, and CD3 /CD16+/CD56+ natural killer cells . Quadrant 2: CD3+ 
T lymphocytes, CD19+ B  lymphocytes, and CD15+ contaminating granulocytes. Quadrant 
3: Unidentified events.
Table 1 Composition of “lympho-gate”in neonatal and adult blood samples*
blood with and without a correction for 
normoblasts and unlysed erythrocytes are 
shown in table 2 for two samples. Normoblasts 
were not found by manual diVerentiation or 
flow cytometric immunophenotyping in blood 
samples from the same neonates at 1 week of 
age nor in blood samples from adults, but 
unlysed erythrocytes were still present in some 
samples at 1 week of age (table 1).
D iscussion
We have developed a microassay for flow cyto­
metric determination of blood lymphocyte 
subpopulations in neonates and young infants 
by adapting the lysed whole blood technique, 
using one step triple immunostaining. When 
only double immunostaining is available, more 
blood is needed and less detailed results are 
obtained—for example, double positive 
CD45RA+/CD45RO+ CD3+ T lymphocytes 
cannot be identified. This micro-assay needs 
only about 0.4 ml of blood to determine T 
lymphocyte subpopulations for monitoring 
HIV infected infants, and 0.5 to 0.8 ml of 
blood is sufficient for detailed evaluation of 
infants with suspected congenital immunodefi­
ciencies. Extensive protocols for research 
purposes can also be performed, because 
1.0 ml of blood is sufficient for more than 40 
triple immunostainings. These are acceptable 
volumes in infants and even in preterm babies.
Normoblasts and unlysed erythrocytes can 
be present in considerable numbers in neonatal 
samples.4 The presence of normoblasts cannot 
be prevented by technical measures, but strict 
adherence to a rigorous lysing protocol can 
minimise the number of unlysed erythrocytes 
in a sample. Therefore, identification of both 
cell populations is of interest. Using triple
Lympho-gate populations
Preterm neonates (n=6) Term neonates (n=--15)
The same neonates at one week 
of age (one preterm and 13 
term neonates)
Adults
(n=9)
Mean Median Range Mean Median Range Mean Median Range Mean Median Range
Lympho-sumt 57 61 24-78 85 86 67-95 95 96 92-98 98 98 97-100
CD14+ monocytes 2 2 1-2 1 1 0-3 1 1 0-2 1 1 0-2
CD15+ granulocytes 1 1 0-1 1 1 0-1 1 1 0-1 0 0 0-1
CD71+/GpA+/CD45- normoblasts 31 29 8-57 10 7 3-28 0 0 0-1 0 0 0-0
CD71-/GpA+/CD45- unlysed erythrocytes 4 3 2-5 2 1 0-11 2 1 0-8 1 1 0-2
* All numbers represent percentages.
t  Lympho-sum = CD19+ + CD3+ + CD3-CD16/56+ (B+T+NK) without correction for the erythroid cell contamination of the lympho-gate.
FSC CD71(66IG10)-FITC
e 2 Triple staining for CD71, GpA, and CD45 identifies normoblasts and unlysed erythrocytes within the lympho-gate. (A) Lympho-gate setting. 
(B) CD71+IGpA+ICD45 population of normoblasts and the CD71IGpA+ICD45- population of unlysed erythrocytes within the CD45 lympho-gate. (C) 
Back-gating of CD71+IGpA+ICD45- normoblasts into the lympho-gate. (D) Back-gating of and CD71IGpA+ICD45- unlysed erythrocytes into the 
lympho-gate.
Microassay for immunophenotyping neonatal lymphocytes
Table 2 Illustration of erythroid cell contamination bias in two cord blood samples*
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Erythroid cells within CD3 CD16/56 natural
“lympho-gate” CD3+T lymphocytes CD19+ B  lymphocytes killer cells Lympho-sum
Gestational age Normoblasts Unlysed Uncorrectedf Corrected$ Uncorrectedf Corrected$ Uncorrectedf Corrected$ Uncorrectedf Corrected$
29 weeks 44 5 28 54 18 36 10 20 56 110
35 weeks 40 3 24 43 10 17 17 30 51 89
* All numbers represent percentages.
t  Without correction for the erythroid contamination of the lympho-gate. 
$ With correction for the erythroid contamination of the lympho-gate.
immunostaining for CD71, GpA, and CD45, 
we were able to identify both normoblasts 
(CD71+/GpA+/CD45- cells) and unlysed eryth­
rocytes (CD71-/ GpA+/CD45- cells) within the 
lympho-gate, and to measure their relative fre­
quencies. When only double immunostaining is 
available, GpA+/CD45- cells can be used to 
measure the relative frequency of erythroid 
cells, but normoblasts and unlysed erythrocytes 
cannot be identified separately. The relative fre­
quencies of erythroid cells can be used to calcu­
late the correct relative frequencies of blood 
lymphocyte subpopulations. This is especially 
important in preterm neonatal and prenatal 
blood samples, where the relative frequencies of 
normoblasts and unlysed erythrocytes can be 
high (tables 1 and 2),6 and the frequencies of 
lymphocyte subpopulations can be underesti­
mated. This can be confusing if a congenital 
immunodeficiency is suspected. The erythroid 
cell contamination of the lympho-gate rapidly 
disappears after birth and is virtually absent by 
1 week of age (table 1).
In conclusion, we have developed a fast and 
easy to use lysed whole blood microassay for 
immunophenotyping of neonatal and infant
blood lymphocyte subpopulations. It requires 
only a small volume of blood (20 ^l per test 
tube), and offers a method to correct for the 
presence of normoblasts and unlysed erythro­
cytes in neonatal samples. It would also be 
suitable for rapid prenatal immunodiagnosis of 
congenital immunodeficiencies when genetic 
markers are not available.7
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